GlaxoSmithKline grants researchers access to clinical trial data

@article{Coombes2012GlaxoSmithKlineGR,
  title={GlaxoSmithKline grants researchers access to clinical trial data},
  author={R. Coombes},
  journal={BMJ : British Medical Journal},
  year={2012},
  volume={345}
}
  • R. Coombes
  • Published 2012
  • Medicine
  • BMJ : British Medical Journal
  • GlaxoSmithKline has taken steps to open up more clinical data behind its drug trials, just months after the company was fined a record amount for ethical breaches. From January all anonymised patient level data that sit hidden behind the results of clinical trials of its approved and failed drugs will be available without charge through a secure website once access has been approved. Andrew Witty, GSK’s chief executive, said that the move sprang from a desire to dismiss the perception that… CONTINUE READING
    12 Citations

    Topics from this paper

    GSK backs campaign for disclosure of trial data
    • 13
    GSK backs BMJ’s new policy to publish only studies with full access to data
    • 1
    Computational Drug Repositioning: From Data to Therapeutics
    • 231
    Is Biblioleaks Inevitable?
    • 20
    Clinical trial data for all drugs in current use
    • F. Godlee
    • Medicine
    • BMJ : British Medical Journal
    • 2012
    • 57
    • PDF
    The Tamiflu trials
    • 20
    Conflicts of interest in biomedical publishing
    • PDF

    References

    GlaxoSmithKline is fined record $3bn in US
    • B. Roehr
    • Medicine
    • BMJ : British Medical Journal
    • 2012
    • 17